NVAX went from ~$8.50 to a $1.20 in one trading day after a failure on an elderly RSV vaccine failure. Hope you bought yourself some insurance.
I think Bruce Givens said on the call that with infants it is different in that they are disease naive. They are infants in the womb, never been exposed to RSV as say maybe an elderly person has and just fought off the disease on their own so it's the purest form of a test to see if the vaccine provided protection. The risk of course is if there was something screwy in the manufacturing process (which they said there wasn't) but remains to be seen. Good luck to all!
imfournursebee emerges fresh from the basement team motivational speech. It went something like this: "Guys, this NVAX thing has gotten out of hand. We no longer control the narrative or the share price. Now let's get out there and drive this sucker down. Top (basher) message producer for the month gets a FREE ham sandwich. imfournursebee, now I'm counting on YOU. NOW GO GET 'EM".
Another year older...another year of making sheeyat up. Look forward to your "updates later" when you tell us all what happened AFTER it happens. #Profound